Endeavor BioMedicines Employee Directory
Biotechnology ResearchCalifornia, United States11-50 Employees
Endeavor BioMedicines is a clinical-stage biotechnology company based in San Diego, California, concentrating on medicines intended to deliver meaningful clinical benefits for patients facing life-threatening diseases. Its lead investigational candidate, ENV-101, inhibits the Hedgehog signaling pathway and is being developed for idiopathic pulmonary fibrosis and progressive pulmonary fibrosis. A second candidate, ENV-501, is an antibody-drug conjugate targeted at HER3, developed for HER3-positive solid tumors. Operating in the biotechnology research sector, Endeavor focuses on therapies for fibrotic lung disease and cancer. The company maintains a relatively small to mid-sized team. In May 2025, the company announced that two posters were accepted for presentation at the American Thoracic Society 2025 International Conference.